granted
on 19 Mar 2024
Last Applicant/ Owned by
600 Stewart St., Suite 300
Seattle
WA
98101
Serial Number
97520536 filed on 26th Jul 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis;Read More
Providing medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine
Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biology, artificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
Medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments for use in oncology
Downloadable and recorded medical software for drug discovery; Downloadable and recorded software for analyzing microscopy data; Downloadable and recorded computer programs using artificial intelligence for use in machine learning; Downloadable and recorded bioinformatics software; Downloadable and recorded computer application software for in silico drug design and image processing; Downloadable and recorded software for use in the evaluation and analysis of data utilizing machine learning; Downloadable and recorded microscope operating software and microscope accessories in the nature of electron microscope operational parameters, namely, electron beam control, detector apparatus, and sample handling and positioning controls
Reagents for medical use; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the treatment of aberrant protein function; Antitumor drugs; chemotherapeutics; Pharmaceutical preparations for the treatment of cancer, neurological, inflammatory or metabolic diseases; Therapeutic agents for the treatment of cancer, neurological, inflammatory or metabolic diseases; Diagnostic biomarker reagents for medical purposes
No 97520536
No Service Mark
No 140846347327
Yes
No
No
No
No
No
No
No
24.15.04 -
Arrowheads
The mark consists of the words "GANDEEVA THERAPEUTICS" together with an arrowhead design on the left.
| Status Date | Action Taken |
|---|---|
| 20th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 19th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 19th Mar 2024 | SOU EXTENSION 1 FILED |
| 19th Mar 2024 | SOU EXTENSION 1 GRANTED |
| 26th Sep 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 01st Aug 2023 | PUBLISHED FOR OPPOSITION |
| 01st Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 12th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 22nd Jun 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 22nd Jun 2023 | EXAMINERS AMENDMENT E-MAILED |
